Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Karafilidis

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Urolithiasis|April 17, 2023
Healthcare utilization, quality of life, and work productivity associated with primary hyperoxaluria: a cross-sectional web-based US surveyDavid S Goldfarb, Frank Modersitzki, John Karafilidis, et al.
Journal of Medical Economics|June 20, 2013
Risk of all-cause hospitalization in COPD patients initiating long-acting or short-acting beta agonist therapyVamsi Bollu, Flavia Ejzykowicz, Krithika Rajagopalan, et al.
Allergy and Asthma Proceedings|June 25, 2009
Efficacy and safety evaluation of ciclesonide in subjects with mild-to-moderate asthma not currently using inhaled corticosteroidsWilliam E Berger, Edward Kerwin, David I Bernstein, et al.
Journal of Clinical Pharmacology|June 5, 2002
A new solution-based intranasal triamcinolone acetonide formulation in patients with perennial allergic rhinitis: how does the pharmacokinetic/pharmacodynamic profile for cortisol suppression compare with an aqueous suspension-based formulation?Günther Hochhaus, Mario A González, Robert J Dockhorn, et al.
Allergy and Asthma Proceedings|June 25, 2009
Efficacy and safety evaluation of ciclesonide in mild-to-moderate persistent asthma previously treated with inhaled corticosteroidsEli O Meltzer, Phillip E Korenblat, Steven F Weinstein, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 20, 2013
Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPDVamsi Bollu, Frank R Ernst, John Karafilidis, et al.
The Journal of Urology|August 5, 2022
Diagnostic Code-Based Screening for Identifying Children with Primary HyperoxaluriaGregory Tasian, Kimberley Dickinson, John Karafilidis, et al.
European Journal of Pediatrics|July 1, 2023
The real world experience of pediatric primary hyperoxaluria patients in the PEDSnet clinical research networkChristina B Ching, Kimberley Dickinson, John Karafilidis, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Urolithiasis|April 17, 2023
Healthcare utilization, quality of life, and work productivity associated with primary hyperoxaluria: a cross-sectional web-based US surveyDavid S Goldfarb, Frank Modersitzki, John Karafilidis, et al.
Journal of Medical Economics|June 20, 2013
Risk of all-cause hospitalization in COPD patients initiating long-acting or short-acting beta agonist therapyVamsi Bollu, Flavia Ejzykowicz, Krithika Rajagopalan, et al.
Allergy and Asthma Proceedings|June 25, 2009
Efficacy and safety evaluation of ciclesonide in subjects with mild-to-moderate asthma not currently using inhaled corticosteroidsWilliam E Berger, Edward Kerwin, David I Bernstein, et al.
Journal of Clinical Pharmacology|June 5, 2002
A new solution-based intranasal triamcinolone acetonide formulation in patients with perennial allergic rhinitis: how does the pharmacokinetic/pharmacodynamic profile for cortisol suppression compare with an aqueous suspension-based formulation?Günther Hochhaus, Mario A González, Robert J Dockhorn, et al.
Allergy and Asthma Proceedings|June 25, 2009
Efficacy and safety evaluation of ciclesonide in mild-to-moderate persistent asthma previously treated with inhaled corticosteroidsEli O Meltzer, Phillip E Korenblat, Steven F Weinstein, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 20, 2013
Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPDVamsi Bollu, Frank R Ernst, John Karafilidis, et al.
The Journal of Urology|August 5, 2022
Diagnostic Code-Based Screening for Identifying Children with Primary HyperoxaluriaGregory Tasian, Kimberley Dickinson, John Karafilidis, et al.
European Journal of Pediatrics|July 1, 2023
The real world experience of pediatric primary hyperoxaluria patients in the PEDSnet clinical research networkChristina B Ching, Kimberley Dickinson, John Karafilidis, et al.
Pageof 1